Works matching IS 01145916 AND DT 2023 AND VI 46 AND IP 3

Results: 10

Use of Structured Electronic Health Records Data Elements for the Development of Computable Phenotypes to Identify Potential Adverse Events Associated with Intravenous Immunoglobulin Infusion.

Published in:

Drug Safety, 2023, v. 46, n. 3, p. 309, doi. 10.1007/s40264-023-01276-6

By:

Hurst, Jillian H.;
Brucker, Amanda;
Zhao, Congwen;
Driscoll, Hannah;
Hostetler, Haley P.;
Phillips, Michael;
Rosenberg, Bari;
Samsky, Marc D.;
Smith, Isaac;
Reller, Megan E.;
Strouse, John J.;
Zhou, Cindy Ke;
Dores, Graça M.;
Wong, Hui-Lee;
Goldstein, Benjamin A.

Publication type:

Article

Optimizing Safety Surveillance for COVID-19 Vaccines at the Swedish Medical Products Agency.

Published in:

Drug Safety, 2023, v. 46, n. 3, p. 319, doi. 10.1007/s40264-023-01275-7

By:

Kälkner, Karl Mikael;
Sundström, Anders;
Nurminen, Marja-Leena;
Larsson, Maria;
Ljung, Rickard;
Arthurson, Veronica

Publication type:

Article

Correction to: Individual Case Safety Report Replication: An Analysis of Case Reporting Transmission Networks.

Published in:

2023

By:

van Stekelenborg, John;
Kara, Vijay;
Haack, Roman;
Vogel, Ulrich;
Garg, Anju;
Krupp, Markus;
Gofman, Kate;
Dreyfus, Brian;
Hauben, Manfred;
Bate, Andrew

Publication type:

Correction Notice

The COVID-19 Vaccines International Pregnancy Exposure Registry (C-VIPER): Protocol and Methodological Considerations.

Published in:

Drug Safety, 2023, v. 46, n. 3, p. 297, doi. 10.1007/s40264-022-01271-3

By:

Wyszynski, Diego F.;
Bhattacharya, Mondira;
Martínez-Pérez, Oscar;
Scialli, Anthony R.;
Tassinari, Melissa;
Bar-Zeev, Naor;
Renz, Cheryl;
Hernández-Díaz, Sonia

Publication type:

Article

What Factors Make EU Regulators Want to Communicate Drug Safety Issues Related to SGLT2 Inhibitors? An Online Survey Study.

Published in:

Drug Safety, 2023, v. 46, n. 3, p. 243, doi. 10.1007/s40264-022-01270-4

By:

Roldan Munoz, Sonia;
Postmus, Douwe;
de Vries, Sieta T.;
Gross-Martirosyan, Liana;
Bahri, Priya;
Hillege, Hans;
Mol, Peter G. M.

Publication type:

Article

Correction: Compliance with Prescribing and Dispensing Conditions for Valproate and Related Substances in Girls and Women of Childbearing Potential: A Survey of Community Pharmacists in France.

Published in:

2023

By:

Fauvelle, Khristina;
Bigna, Jean Joel

Publication type:

Correction Notice

Comparative Safety Analysis of Opioid Agonist Treatment in Pregnant Women with Opioid Use Disorder: A Population-Based Study.

Published in:

Drug Safety, 2023, v. 46, n. 3, p. 257, doi. 10.1007/s40264-022-01267-z

By:

Wang, Shuang;
Meador, Kimford J.;
Pawasauskas, Jayne;
Lewkowitz, Adam K.;
Ward, Kristina E.;
Brothers, Todd N.;
Hartzema, Abraham;
Quilliam, Brian J.;
Wen, Xuerong

Publication type:

Article

Effect of Previous Anticoagulant Treatment on Risk of COVID-19.

Published in:

Drug Safety, 2023, v. 46, n. 3, p. 273, doi. 10.1007/s40264-022-01266-0

By:

Zapata-Cachafeiro, Maruxa;
Prieto-Campo, Ángela;
Portela-Romero, Manuel;
Carracedo-Martínez, Eduardo;
Lema-Oreiro, Martina;
Piñeiro-Lamas, María;
Chaudhuri, Somnath;
Salgado-Barreira, Ángel;
Figueiras, Adolfo

Publication type:

Article

Deliberate Self-Poisoning: Real-Time Characterization of Suicidal Habits and Toxidromes in the Food and Drug Administration Adverse Event Reporting System.

Published in:

Drug Safety, 2023, v. 46, n. 3, p. 283, doi. 10.1007/s40264-022-01269-x

By:

Fusaroli, Michele;
Pelletti, Guido;
Giunchi, Valentina;
Pugliese, Chiara;
Bartolucci, Mattia;
Necibi, Elena Narmine;
Raschi, Emanuel;
De Ponti, Fabrizio;
Pelotti, Susi;
Poluzzi, Elisabetta

Publication type:

Article

Colchicine Drug Interaction Errors and Misunderstandings: Recommendations for Improved Evidence-Based Management.

Published in:

Drug Safety, 2023, v. 46, n. 3, p. 223, doi. 10.1007/s40264-022-01265-1

By:

Hansten, Philip D.;
Tan, Malinda S.;
Horn, John R.;
Gomez-Lumbreras, Ainhoa;
Villa-Zapata, Lorenzo;
Boyce, Richard D.;
Subbian, Vignesh;
Romero, Andrew;
Gephart, Sheila;
Malone, Daniel C.

Publication type:

Article